BACKGROUND AND PURPOSE: Gender differences in inflammation are well described, with females often showing more robust, oestrogen-associated responses. Here, we investigated the influence of gender, oestrogen and the anti-inflammatory protein annexin A1 (AnxA1) on lipopolysaccharide (LPS)-induced leukocyte-endothelial cell interactions in murine cerebral and mesenteric microvascular beds. EXPERIMENTAL APPROACH: Intravital microscopy was used to visualize and quantify the effects of LPS (10 μg·per mouse i.p.) on leukocyte-endothelial interactions in male and female wild-type (WT) mice. The effects of ovariectomy ± oestrogen replacement were examined in WT and AnxA1-null (AnxA1(-/-) ) female mice. KEY RESULTS: LPS increased leukocyte adherence in the cerebral and mesenteric beds of both male and female WT mice; females showed exacerbated responses in the brain versus males, but not the mesentery. Ovariectomy further enhanced LPS-induced adhesion in the brain but not the mesentery; its effects were reversed by oestrogen treatment. OVX AnxA1(-/-) mice also showed exaggerated adhesive responses to LPS in the brain. However, these were unresponsive to ovariectomy and, paradoxically, responded to oestrogen with a pronounced increase in basal and LPS-induced leukocyte adhesion in the cerebrovasculature. CONCLUSIONS AND IMPLICATIONS: Our data confirm the fundamental role of AnxA1 in limiting the inflammatory response in the central and peripheral microvasculature. They also (i) show that oestrogen acts via an AnxA1-dependent mechanism to protect the cerebral, but not the mesenteric, vasculature from the damaging effects of LPS and (ii) reveal a paradoxical and potentially toxic effect of the steroid in potentiating the central response to LPS in the absence of AnxA1.
BACKGROUND AND PURPOSE: Gender differences in inflammation are well described, with females often showing more robust, oestrogen-associated responses. Here, we investigated the influence of gender, oestrogen and the anti-inflammatory protein annexin A1 (AnxA1) on lipopolysaccharide (LPS)-induced leukocyte-endothelial cell interactions in murine cerebral and mesenteric microvascular beds. EXPERIMENTAL APPROACH: Intravital microscopy was used to visualize and quantify the effects of LPS (10 μg·per mouse i.p.) on leukocyte-endothelial interactions in male and female wild-type (WT) mice. The effects of ovariectomy ± oestrogen replacement were examined in WT and AnxA1-null (AnxA1(-/-) ) female mice. KEY RESULTS: LPS increased leukocyte adherence in the cerebral and mesenteric beds of both male and female WT mice; females showed exacerbated responses in the brain versus males, but not the mesentery. Ovariectomy further enhanced LPS-induced adhesion in the brain but not the mesentery; its effects were reversed by oestrogen treatment. OVX AnxA1(-/-) mice also showed exaggerated adhesive responses to LPS in the brain. However, these were unresponsive to ovariectomy and, paradoxically, responded to oestrogen with a pronounced increase in basal and LPS-induced leukocyte adhesion in the cerebrovasculature. CONCLUSIONS AND IMPLICATIONS: Our data confirm the fundamental role of AnxA1 in limiting the inflammatory response in the central and peripheral microvasculature. They also (i) show that oestrogen acts via an AnxA1-dependent mechanism to protect the cerebral, but not the mesenteric, vasculature from the damaging effects of LPS and (ii) reveal a paradoxical and potentially toxic effect of the steroid in potentiating the central response to LPS in the absence of AnxA1.
Authors: D D Henninger; J Panés; M Eppihimer; J Russell; M Gerritsen; D C Anderson; D N Granger Journal: J Immunol Date: 1997-02-15 Impact factor: 5.422
Authors: F Squadrito; D Altavilla; G Squadrito; G M Campo; M Arlotta; V Arcoraci; L Minutoli; M Serrano; A Saitta; A P Caputi Journal: Eur J Pharmacol Date: 1997-09-24 Impact factor: 4.432
Authors: Virginia H Huxley; Scott S Kemp; Christine Schramm; Steve Sieveking; Susan Bingaman; Yang Yu; Isabella Zaniletti; Kevin Stockard; Jianjie Wang Journal: J Physiol Date: 2018-07-15 Impact factor: 5.182
Authors: Ellen L Hughes; Felix Becker; Roderick J Flower; Julia C Buckingham; Felicity N E Gavins Journal: Br J Pharmacol Date: 2017-06-10 Impact factor: 8.739
Authors: Paul M Holloway; Scarlett Gillespie; Felix Becker; Shantel A Vital; Victoria Nguyen; J Steven Alexander; Paul C Evans; Felicity N E Gavins Journal: Vascul Pharmacol Date: 2016-07-08 Impact factor: 5.773